Source: Annual Congress 2009 - Assessment and therapeutical interventions in obstructive sleep apnoea
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Blaukovitsch, E. Müller, S. Rüller, P. Zabel, H. P. Hauber (Borstel, Germany). Effect of nCPAP therapy on inflammatory cell counts in pharyngeal lavage of patients with obstructive sleep apnea. Eur Respir J 2009; 34: Suppl. 53, 3740

Member's Comments

No comment yet.

Related content which might interest you: Nasal inflammation and compliance with nasal CPAP therapy in obstructive sleep apnoea (OSA) Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Effects of nasal continuous positive airway pressure treatment on C-reactive protein in patients with obstructive sleep apnea Source: Annual Congress 2009 - Systemic consequences of sleep-disordered breathing Year: 2009 Nasal continuous airway pressure therapy and respiratory infections in patients with obstructive sleep apnea Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004 Liver function following continuous positive airway pressure therapy in obstructive sleep apnea patients Source: International Congress 2017 – CPAP therapy Year: 2017 Adherence to positive airway pressure in non-sleepy patients with obstructive sleep apnoea Source: Eur Respir J 2013; 42: 863-866 Year: 2013 Nasal surgery improves obstructive sleep apnoea in patients with decreased nasal breathing Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Bronchial inflammation in obstructive sleep apnea (OSA) patients Source: Eur Respir J 2003; 22: Suppl. 45, 466s Year: 2003 Impact of CPAP on asthmatic patients with obstructive sleep apnoea Source: Eur Respir J 2007; 29: 307-311 Year: 2007 The effect of CPAP treatment on Galectin-3 level in patients with severe obstructive sleep apnea Source: International Congress 2018 – Cardiovascular and metabolic consequences of sleep-disordered breathing Year: 2018 Role of CPAP treatment in elderly with moderate obstructive sleep apnea Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects Year: 2019 CPAP therapy in idiopathic pulmonary fibrosis patients with obstructive sleep apnea Source: Annual Congress 2011 - Obstructive sleep apnoea as a comorbidity Year: 2011 Effect of nasal topical steroids on CPAP compliance in patients with obstructive sleep apnoea starting therapy Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Long-term cardiovascular outcomes of patients with obstructive sleep apnoea not treated with nasal CPAP Source: Eur Respir J 2002; 20: Suppl. 38, 294s Year: 2002 Effect of simulated obstructive sleep apnea on thoracic fluid volume and lower airway resistance in asthmatics Source: Virtual Congress 2020 – Diagnostic characteristics and consequences of sleep and breathing disorders Year: 2020 Bronchial reactivity in patients with obstructive sleep apnea syndrome treated with continuous positive airway pressure Source: Eur Respir J 2005; 26: Suppl. 49, 569s Year: 2005 Hypercapnia and respiratory drive in obstructive sleep apnoea patients before and after CPAP treatment Source: Eur Respir J 2002; 20: Suppl. 38, 103s Year: 2002 Continuous positive airway pressure in patients with obstructive sleep apnea: Age-dependent adherence Source: Annual Congress 2010 - Clinical aspects of sleep apnoea Year: 2010 Control of breathing in obstructive sleep apnoea patients: Role of CPAP therapy Source: Annual Congress 2012 - CPAP: beneficial effects on different aspects of health Year: 2012 Airway inflammation in patients with obstructive sleep apnea syndrome Source: Eur Respir J 2002; 20: Suppl. 38, 274s Year: 2002 Effect of upper-airway stimulation for obstructive sleep apnoea on airway dimensions Source: Eur Respir J 2015; 45: 129-138 Year: 2015